Healthy lifestyle and related metabolomic signatures associated with decreased risk and delayed progression of type 2 diabetes mellitus transitions: a large prospective cohort study

IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Peng Hu, Yuqin Wang, Guzhengyue Zheng, Zhengmin (Min) Qian, Ge Chen, Fei Tian, Shengtao Wei, Zitong Zhuang, Michael Elliott, Maya Kavuri, Zhenhe Huang, Hualiang Lin
{"title":"Healthy lifestyle and related metabolomic signatures associated with decreased risk and delayed progression of type 2 diabetes mellitus transitions: a large prospective cohort study","authors":"Peng Hu,&nbsp;Yuqin Wang,&nbsp;Guzhengyue Zheng,&nbsp;Zhengmin (Min) Qian,&nbsp;Ge Chen,&nbsp;Fei Tian,&nbsp;Shengtao Wei,&nbsp;Zitong Zhuang,&nbsp;Michael Elliott,&nbsp;Maya Kavuri,&nbsp;Zhenhe Huang,&nbsp;Hualiang Lin","doi":"10.1007/s00592-026-02764-8","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>To evaluate dynamic associations of a comprehensive healthy lifestyle and related metabolic signatures with the progression trajectory of type 2 diabetes mellitus (T2DM).</p><h3>Methods</h3><p>From the UK Biobank cohort, we identified 305,349 participants without diabetes or diabetes-related complications, 152,901 of whom had available metabolite data. A healthy lifestyle score (HLS) was constructed using eight factors. Elastic net regression models were used to identify lifestyle-related metabolomic signatures. Multistate models were used to evaluate the dynamic associations of HLS and related metabolomic signatures with the incidence and progression of T2DM. Accelerated failure time models assessed whether HLS and related metabolomic signatures were associated with relative time delays in T2DM progression.</p><h3>Results</h3><p>During a median follow-up of 13.84 years, 7998 participants developed incident T2DM. We identified 139 metabolites representing healthy lifestyles. HLS and related metabolomic signatures were inversely associated with the risk of T2DM transitions. The HRs per SD increase of lifestyle-related metabolites were 0.96, 0.89, 0.95, and 0.87 for transitions from non-T2DM to incident T2DM, to death, from incident T2DM to complications, and to death. HLS and related metabolomic signatures were both significantly associated with delays in transitions from non-T2DM to incident T2DM, to death, and from T2DM to complications, to death, with prolonged onset time ranging from 0.22 to 1.75 years for HLS and 0.24 to 0.74 years for metabolomic signatures, respectively.</p><h3>Conclusions</h3><p>The findings highlight the significance of adherence to a healthy lifestyle in preventing the onset and progression of T2DM from behaviors and metabolomics perspectives.</p></div>","PeriodicalId":6921,"journal":{"name":"Acta Diabetologica","volume":"63 10","pages":"1797 - 1809"},"PeriodicalIF":3.1000,"publicationDate":"2026-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Diabetologica","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s00592-026-02764-8","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background

To evaluate dynamic associations of a comprehensive healthy lifestyle and related metabolic signatures with the progression trajectory of type 2 diabetes mellitus (T2DM).

Methods

From the UK Biobank cohort, we identified 305,349 participants without diabetes or diabetes-related complications, 152,901 of whom had available metabolite data. A healthy lifestyle score (HLS) was constructed using eight factors. Elastic net regression models were used to identify lifestyle-related metabolomic signatures. Multistate models were used to evaluate the dynamic associations of HLS and related metabolomic signatures with the incidence and progression of T2DM. Accelerated failure time models assessed whether HLS and related metabolomic signatures were associated with relative time delays in T2DM progression.

Results

During a median follow-up of 13.84 years, 7998 participants developed incident T2DM. We identified 139 metabolites representing healthy lifestyles. HLS and related metabolomic signatures were inversely associated with the risk of T2DM transitions. The HRs per SD increase of lifestyle-related metabolites were 0.96, 0.89, 0.95, and 0.87 for transitions from non-T2DM to incident T2DM, to death, from incident T2DM to complications, and to death. HLS and related metabolomic signatures were both significantly associated with delays in transitions from non-T2DM to incident T2DM, to death, and from T2DM to complications, to death, with prolonged onset time ranging from 0.22 to 1.75 years for HLS and 0.24 to 0.74 years for metabolomic signatures, respectively.

Conclusions

The findings highlight the significance of adherence to a healthy lifestyle in preventing the onset and progression of T2DM from behaviors and metabolomics perspectives.

健康的生活方式和相关的代谢特征与降低2型糖尿病转变的风险和延迟进展相关:一项大型前瞻性队列研究
背景:评估全面健康的生活方式和相关代谢特征与2型糖尿病(T2DM)进展轨迹的动态关联。方法:从英国生物银行队列中,我们确定了305349名无糖尿病或糖尿病相关并发症的参与者,其中152901人有可用的代谢物数据。健康生活方式评分(HLS)由8个因素组成。使用弹性网络回归模型来识别与生活方式相关的代谢组学特征。采用多状态模型评估HLS和相关代谢组学特征与T2DM发病和进展的动态关联。加速失效时间模型评估HLS和相关代谢组学特征是否与T2DM进展的相对时间延迟相关。结果:在13.84年的中位随访期间,7998名参与者发生了T2DM。我们确定了139种代表健康生活方式的代谢物。HLS和相关代谢组学特征与T2DM转变的风险呈负相关。在从非T2DM到T2DM、从T2DM到死亡、从T2DM到并发症和死亡的转变中,生活方式相关代谢物每SD增加的hr分别为0.96、0.89、0.95和0.87。HLS和相关的代谢组学特征均与从非T2DM到T2DM、到死亡、从T2DM到并发症、到死亡的过渡延迟显著相关,HLS的发病时间延长为0.22至1.75年,代谢组学特征延长为0.24至0.74年。结论:从行为和代谢组学的角度来看,研究结果强调了坚持健康的生活方式在预防T2DM发病和进展中的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Acta Diabetologica
Acta Diabetologica 医学-内分泌学与代谢
CiteScore
7.30
自引率
2.60%
发文量
180
审稿时长
2 months
期刊介绍: Acta Diabetologica is a journal that publishes reports of experimental and clinical research on diabetes mellitus and related metabolic diseases. Original contributions on biochemical, physiological, pathophysiological and clinical aspects of research on diabetes and metabolic diseases are welcome. Reports are published in the form of original articles, short communications and letters to the editor. Invited reviews and editorials are also published. A Methodology forum, which publishes contributions on methodological aspects of diabetes in vivo and in vitro, is also available. The Editor-in-chief will be pleased to consider articles describing new techniques (e.g., new transplantation methods, metabolic models), of innovative importance in the field of diabetes/metabolism. Finally, workshop reports are also welcome in Acta Diabetologica.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书